Tower Research Capital (TRC)’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.7K | Sell |
|
|||||
|
2025
Q2 | $19.9K | Buy |
|
|||||
|
2025
Q1 | $13.6K | Sell |
|
|||||
|
2024
Q4 | $19.9K | Buy |
|
|||||
|
2024
Q3 | $15.1K | Sell |
|
|||||
|
2024
Q2 | $73.6K | Buy |
|
|||||
|
2024
Q1 | $27.1K | Sell |
|
|||||
|
2023
Q4 | $186K | Buy |
|
|||||
|
2023
Q3 | $26.1K | Sell |
|
|||||
|
2023
Q2 | $67.8K | Buy |
|
|||||
|
2023
Q1 | $42K | Sell |
|
|||||
|
2022
Q4 | $104K | Sell |
|
|||||
|
2022
Q3 | $295K | Buy |
|
|||||
|
2022
Q2 | $210K | Sell |
|
|||||
|
2022
Q1 | $243K | Buy |
|
|||||
|
2021
Q4 | $221K | Buy |
|
|||||
|
2021
Q3 | $316K | Buy |
|
|||||
|
2021
Q2 | $162K | Buy |
|
|||||
|
2021
Q1 | $182K | Sell |
|
|||||
|
2020
Q4 | $133K | Buy |
|
|||||
|
2020
Q3 | $130K | Sell |
|
|||||
|
2020
Q2 | $556K | Buy |
|
|||||
|
2020
Q1 | $1K | Sell |
|
|||||
|
2019
Q4 | $110K | Buy |
|
|||||
|
2019
Q3 | $78K | Buy |
|
|||||
|
2019
Q2 | $2K | Buy |
|